The research aimed to determine, for the ACT: relevant patterns of drug use, stakeholder views on gaps in drug harm minimisation services, stakeholder views on the need for a drug consumption room, and processes required for the implementation of a drug consumption room.
2020
The research included a desktop review, qualitative interviews, quantitative interviews and snapshot surveys.
Desktop review: a desktop review was conducted to: (a) identify and review existing materials on the establishment of drug consumption rooms including service models and design along with costings available in the public domain, and (b) identify and synthesise data sources that capture information on drug use and drug related harms in the ACT.
Qualitative interviews: 27 qualitative in depth interviews with service providers, policymakers and consumer representatives in the ACT, NSW and VIC as well as internationally as appropriate
Quantitative interviews: 101 quantitative interviews with service users conducted by workers at the Canberra Alliance for Harm Minimisation and Advocacy (CAHMA);
Snapshot surveys: the BI team supported and trained selected services to undertake snapshot surveys with needle and syringe program clients which add a small number of additional questions to those routinely asked of all clients when they access services in the ACT.
The study provided evidence on whether a supervised drug consumption room/s is suited to the ACT context and, if so, what form such a facility should take.
Partners +
Collaborators
- Chris Gough, Canberra Alliance for Harm Minimisation and Advocacy
Project
Team
Meet the project team. Together, we are translating research into better health, for all.
